ProSomnus (ProSomnus) EV-to-Revenue : 1.29 (As of May. 15, 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProSomnus EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ProSomnus's enterprise value is $35.70 Mil. ProSomnus's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $27.65 Mil. Therefore, ProSomnus's EV-to-Revenue for today is 1.29.

The historical rank and industry rank for ProSomnus's EV-to-Revenue or its related term are showing as below:

OSAPQ' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.28 Med: 2.24 Max: 6.58
Current: 1.29

During the past 4 years, the highest EV-to-Revenue of ProSomnus was 6.58. The lowest was 1.28. And the median was 2.24.

OSAPQ's EV-to-Revenue is ranked better than
78.36% of 827 companies
in the Medical Devices & Instruments industry
Industry Median: 3.19 vs OSAPQ: 1.29

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), ProSomnus's stock price is $0.0401. ProSomnus's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.64. Therefore, ProSomnus's PS Ratio for today is 0.02.

ProSomnus EV-to-Revenue Historical Data

The historical data trend for ProSomnus's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProSomnus EV-to-Revenue Chart

ProSomnus Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

5.48

1.88

ProSomnus Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial							5.48	5.01	3.46	1.80	1.88

Competitive Comparison of ProSomnus's EV-to-Revenue

For the Medical Devices subindustry, ProSomnus's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProSomnus's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ProSomnus's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where ProSomnus's EV-to-Revenue falls into.

ProSomnus EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

ProSomnus's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	35.702	/	27.651
	=	1.29

ProSomnus's current Enterprise Value is $35.70 Mil.
ProSomnus's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $27.65 Mil.

ProSomnus (OTCPK:OSAPQ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

ProSomnus's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.0401	/	1.638
	=	0.02

ProSomnus's share price for today is $0.0401.
ProSomnus's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.64.

ProSomnus EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of ProSomnus's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

ProSomnus (ProSomnus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ProSomnus Inc (OTCPK:OSAPQ) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

5675 Gibraltar Drive, Pleasanton, CA, USA, 94588

Website

https://www.prosomnus.com

ProSomnus Inc is a medical device manufacturer. It manufacturers precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus's patented devices are more comfortable and less invasive alternative to continuous positive airway pressure therapy, and lead to more effective and patient-preferred outcomes.

Executives

Sung Kim	officer: Chief Technical Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
John Steffens	10 percent owner	C/O DIGITALBRIDGE GROUP, INC., 750 PARK OF COMMERCE DRIVE SUITE 210, BOCCA RATON FL 33487
Gregory P. Ho	10 percent owner	C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Brian B Dow	officer: Chief Financial Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Smc Holdings Ii, Lp	10 percent owner	65 EAST 55TH STREET, 33RD FLOOR, NEW YORK NY 10022
Smc Holdings Ii G.p., Llc	10 percent owner	C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Laing Rikkers	director	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Len Liptak	director, officer: Chief Executive Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Mark Thomas Murphy	officer: Chief Growth Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Hgp Iii, Llc	10 percent owner	3708 ASHFORD PLACE, GREENVILLE NC 27858
Steven Robert Pacelli	director	5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Hmc, Llc	10 percent owner	3708 ASHFORD PLACE, GREENVILLE NC 27858
Healthpointcapital, Llc	10 percent owner	C/O HEALTHPOINTCAPITAL, 505 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Healthpointcapital Partners Iii Lp	10 percent owner	505 Park Avenue, 12th Floor, New York NY 10022
Leonard Hedge	director	7855 BELLA MONTANIA LANE, PALO CEDRO CA 96073